Bank Julius Baer & Co. Ltd Zurich Trims Stock Position in Synopsys, Inc. $SNPS

Bank Julius Baer & Co. Ltd Zurich trimmed its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 92.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,141 shares of the semiconductor company’s stock after selling 26,825 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Synopsys were worth $1,098,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Saudi Central Bank acquired a new position in Synopsys during the first quarter worth $26,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Synopsys by 441.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 53 shares in the last quarter. Independence Bank of Kentucky raised its position in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 30 shares during the last quarter. Princeton Global Asset Management LLC lifted its stake in Synopsys by 481.8% in the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 53 shares in the last quarter. Finally, WPG Advisers LLC acquired a new stake in Synopsys in the 1st quarter worth about $34,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Trading Up 0.7%

Shares of SNPS stock opened at $388.36 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. The stock has a market capitalization of $72.14 billion, a P/E ratio of 30.48, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. The company has a 50 day moving average price of $444.36 and a 200 day moving average price of $510.39. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPS) last released its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the firm earned $3.43 earnings per share. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Equities research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Transactions at Synopsys

In other news, CFO Shelagh Glaser sold 3,655 shares of Synopsys stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the transaction, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert G. Painter bought 350 shares of the firm’s stock in a transaction dated Thursday, September 11th. The shares were acquired at an average price of $425.44 per share, with a total value of $148,904.00. Following the purchase, the director directly owned 2,291 shares of the company’s stock, valued at approximately $974,683.04. This trade represents a 18.03% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have sold 30,894 shares of company stock worth $16,760,783. 0.62% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently commented on SNPS shares. Morgan Stanley dropped their price target on Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a research report on Thursday, September 11th. JPMorgan Chase & Co. dropped their target price on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Piper Sandler reduced their target price on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Citigroup lowered shares of Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. Finally, Mizuho dropped their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a research note on Thursday, September 11th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Synopsys currently has an average rating of “Hold” and a consensus price target of $562.14.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.